SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-09-174998
Filing Date
2009-08-14
Accepted
2009-08-14 06:10:00
Documents
6
Period of Report
2009-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 667420
2 WAIVER AND AMENDMENT AGREEMENT dex43d.htm EX-4.3D 49034
3 AMENDMENT NO. 5 TO LICENSE AGREEMENT dex1090.htm EX-10.90 7946
4 CERTIFICATION OF CEO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) dex311.htm EX-31.1 9919
5 CERTIFICATION OF ACTING PFO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) dex312.htm EX-31.2 9947
6 CERTIFICATIONS OF CEO AND ACTING PFO PURSUANT TO 18 U.S.C. SECTION 1350 dex321.htm EX-32.1 4998
  Complete submission text file 0001193125-09-174998.txt   750648
Mailing Address 3180 PORTER DRIVE PALO ALTO CA 94304
Business Address 3180 PORTER DRIVE PALO ALTO CA 94304 650-496-3777
JAZZ PHARMACEUTICALS INC (Filer) CIK: 0001232524 (see all company filings)

IRS No.: 050563787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33500 | Film No.: 091012158
SIC: 2834 Pharmaceutical Preparations